top of page

myLaminin Perspectives
Insights on Research Compliance, Clinical Trials & Data Management


ICH E6(R3) Clinical Trial Compliance: Is Your CTMS Ready for the Biggest Regulatory Shift in a Decade?
The new ICH E6(R3) guidelines are transforming clinical research worldwide, requiring Quality-by-Design, risk-based oversight, and validated digital systems. Discover how myLaminin's co-designed Clinical Trial Operations (CTOps) and CTMS platform helps research teams, principal investigators, administrators, and compliance professionals streamline operations, strengthen data integrity, improve audit readiness, and meet evolving global regulatory requirements with confidence.

Ash Bassili
Jun 194 min read


Rising Clinical Trial Costs: Key Drivers and How Sponsors Can Reduce Expenses
Rising clinical trial costs are driven by growing protocol complexity, recruitment challenges, site capacity limits, regulatory burdens, and expanding data demands. These inefficiencies strain sponsors and delay outcomes. By adopting quality-by-design, optimizing protocols, improving patient engagement, and leveraging integrated CTMS and RDM platforms, organizations can reduce costs, enhance compliance, and accelerate clinical research while maintaining data integrity.

myLaminin
Mar 176 min read


CoreTrustSeal Certification: What Is It? Why Get It? Why Look For It?
CoreTrustSeal certification sets the global baseline for trustworthy research data repositories. This article explains what CoreTrustSeal is, why institutions pursue it, and why researchers and funders should look for it. Learn how certification supports data integrity, long-term preservation, FAIR principles, regulatory compliance, and open science—and how platforms like myLaminin help organizations achieve CoreTrustSeal readiness efficiently.

Darina Dragouleva
Feb 93 min read
bottom of page